Mental Illness: What Both Frameworks Are Protecting

Nadia was twenty-six when she received a diagnosis of bipolar disorder. Looking back, she can see it in the decade before — the stretches of four hours' sleep and absolute certainty that she was on the verge of something transformative, followed by months when getting out of bed before noon felt like lifting a ceiling. Two relationships had ended because of behavior she could not explain at the time. She had left three jobs. Her therapist, after months of careful attention, referred her to a psychiatrist, who prescribed a mood stabilizer. Within six weeks, the cycling slowed to a pace she could live inside. She was enormously grateful, and she was also troubled by something she couldn't quite name — a feeling that the diagnosis had explained her to herself in a way that was true and also incomplete, that the frame "your brain does this" had relieved her of a kind of self-recrimination she had been carrying for years while also, quietly, releasing her from a different kind of inquiry. It had named a mechanism. It had not asked what the mechanism was responding to.

James was thirty-two when he was diagnosed with major depressive disorder. In the prior eighteen months, his startup had collapsed under him, his marriage had ended, and he had lost the apartment he and his wife had shared. His GP, during a routine check-in, asked a series of questions about sleep and concentration and interest in activities. James scored poorly on all of them. He was prescribed an SSRI and referred to a counselor. The medication helped him function: he could get through a workday, answer emails, be present enough in conversations to pass as fine. What it did not do was touch the question that felt most urgent to him — whether the life he had been living was worth rebuilding, whether the despair that descended after its collapse was a symptom or a response. His counselor, working in an eight-session framework focused on cognitive restructuring, helped him identify "maladaptive thought patterns." James complied, and privately felt that calling his grief about his failures a maladaptive pattern was a sophisticated way of asking him not to think about what had actually happened.

Both Nadia and James were helped by the medical system. Both of them were also left with something the medical frame did not address. These are not stories about psychiatry failing — they are stories about what the dominant framework for understanding mental distress makes visible and what it leaves in shadow. The argument between the medical/ biological model and the psychosocial tradition is not, at its core, about whether distress is real or whether people deserve help. It is about what kind of help is honest — and what we lose when we name suffering without asking what it is a response to.

What the medical/biological model is protecting

The medical model is protecting the reality of severe mental illness as a distinct category of suffering. The strongest case for psychiatry is not depression or anxiety — where the boundary between clinical disorder and normal suffering under difficult circumstances is genuinely blurry — but schizophrenia, severe bipolar disorder, and catatonia: conditions that produce breaks with shared reality, destroy relationships and careers, and cause profound suffering that does not respond to changed circumstances alone. E. Fuller Torrey, in Surviving Schizophrenia (Harper Perennial, 1983; 7th ed. 2019), makes this case with clinical urgency: schizophrenia is among the most disabling conditions in the world, it has measurable neurological correlates, it runs in families in patterns consistent with genetic contribution, and it responds to antipsychotic medication in ways that have allowed many people who would otherwise be permanently institutionalized to live in the community. The critics of psychiatry, Torrey argues, have had the luxury of focusing on overdiagnosis and overtreatment precisely because the undertreatment of severe cases is not what they or their readers typically encounter. The biomedical model's most honest defense is not that it explains all mental distress but that it provides the most effective tools currently available for its most devastating forms.

The model is protecting relief from moral blame — and this is not a trivial protection. Before the medical frame, severe mental distress was explained through moral failure, demonic possession, weakness of character, or bad parenting. The shift to illness language was, for many people, a genuine liberation: if you have a disease, you are not at fault. Nadia experienced this directly — the diagnosis gave her a way to understand the wreckage of her twenties that did not require concluding that she was simply a selfish or unreliable person. For families of people with severe illness, the medical frame offers similar relief: the parent of a person with schizophrenia is not the cause of their child's condition, and a model that says so is protecting something worth protecting. The question that critics raise — whether pathologizing suffering also removes people from their own story — does not erase the real harm that the moral-blame alternative caused and still causes.

The model is protecting access to treatment within a system built around the illness frame. In contemporary healthcare, receiving psychiatric care — hospital admission, medication, specialist referral, insurance coverage — typically requires a diagnosis. This is a structural fact with practical consequences: whatever the theoretical merits of the psychosocial critique, refusing diagnosis can mean refusing access to whatever help the system offers. The medical model also protects the claim that psychiatric conditions deserve resources on par with physical illness — a claim that reformers have spent decades advancing against the persistent assumption that depression is just sadness and anxiety is just worry. The parity argument depends on the illness frame: if mental distress is not a disease, it is harder to argue that it warrants the same insurance coverage, the same research funding, the same clinical seriousness as diabetes or cancer.

What the psychosocial/critical tradition is protecting

The psychosocial and critical psychiatry traditions are protecting the meaning of distress. The core claim of the tradition — associated with Thomas Szasz, R.D. Laing, and developed more recently by researchers like Lucy Johnstone and Mary Boyle — is that most mental suffering is a response to something: to trauma, poverty, abuse, isolation, profound loss, structural injustice, or the ordinary devastation of certain kinds of lives. The Power Threat Meaning Framework, developed by Lucy Johnstone, Mary Boyle, and colleagues at the British Psychological Society (2018), proposes replacing the question "What is wrong with you?" with "What has happened to you? How has it affected you? What sense have you made of it?" The framework does not deny the reality of distress. It insists that distress is usually intelligible — that if you know enough about someone's life, the suffering usually makes sense — and that treating it as a symptom of a disease inside the person can cut off exactly the inquiry that might lead somewhere useful. James's GP gave him a diagnosis that named his brain state and left his collapsed life untouched. The psychosocial tradition would say this was not a neutral act but a choice about where to locate the problem — and that choice had consequences for what counted as a solution.

The tradition is protecting an honest account of what the science actually shows. The "chemical imbalance" theory of depression — the idea that depression is caused by low serotonin levels, corrected by SSRIs — was the dominant public narrative for several decades and shaped millions of treatment decisions. A 2022 umbrella review by Joanna Moncrieff and colleagues, published in Molecular Psychiatry, found no consistent evidence that people with depression have lower serotonin levels or activity than people without depression, and no evidence that SSRIs work by correcting a serotonin deficit. This was not a fringe finding — it appeared in a peer-reviewed journal and was widely noted in mainstream psychiatry, which has largely moved away from the simple serotonin story (though without always updating the public narrative). Robert Whitaker, in Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America (Crown Publishers, 2010), marshals a broader concern: that long-term outcomes data for many psychiatric conditions show worse trajectories in countries with high psychiatric drug use than in countries with lower use — a pattern that raises questions about whether some medication regimens, especially over the long term, may be maintaining rather than resolving the conditions they treat. This evidence is contested, and the critique does not apply equally to all medications for all conditions. But the psychosocial tradition is protecting the right to ask the question — and to have the answer taken seriously rather than dismissed as dangerous irresponsibility.

The tradition is protecting the rights, voice, and self-determination of the people the system is most likely to coerce. Psychiatric patients have historically occupied a peculiar legal and social position: diagnosed with a condition that is then used to discount their own account of their experience. The survivor and service user movement — organized under names like Mad Pride, Hearing Voices Network, and the broader neurodiversity frame — insists that people with severe and persistent mental distress are experts on their own experience, that psychiatric hospitalization has been experienced by many as trauma rather than treatment, and that the diagnostic frame can function as a way of invalidating the person's own interpretation of what is happening to them. Allan Horwitz and Jerome Wakefield, in The Loss of Sadness: How Psychiatry Transformed Normal Sorrow into Depressive Disorder (Oxford University Press, 2007), document the specific way DSM criteria have progressively removed context from the definition of depression — eliminating the "bereavement exclusion" that once protected grief from being diagnosed as pathology. What the psychosocial tradition is protecting, at its most fundamental level, is the person's own story: the right to say "this is what happened to me" rather than being told "this is what is wrong with your brain."

Where the real disagreement lives

Is severe mental illness categorically different from mild to moderate distress? The debate is conducted as though "mental illness" were a single thing, but the category spans enormously heterogeneous territory. The psychosocial critique is most compelling at the mild to moderate end — where most people presenting for treatment live, and where the relationship between circumstances and distress is typically legible. It is least compelling as a complete account of schizophrenia or acute mania, where the disconnection from shared reality is not easily explained as a response to circumstances alone, and where the humanitarian case for medication is strongest. The medical model is most compelling at the severe end and least compelling when applied uniformly to the whole range of human suffering. One honest position — held by researchers like Kenneth Kendler and Steven Hyman, who have spent careers in biological psychiatry and arrived at real humility about its limits — is that the field needs different frameworks for different conditions, and that the refusal to make this distinction has caused harm at both ends: undertreating severe psychosis in the name of social critique, and overmedicalizing ordinary misery in the name of clinical care.

What does it mean when medication "works"? Joanna Moncrieff, in The Myth of the Chemical Cure (Palgrave Macmillan, 2008), draws a distinction between the "disease-centered" model of psychiatric drug action (drugs correct a specific biological abnormality, as insulin corrects low blood sugar) and the "drug-centered" model (drugs produce altered mental states that happen to be useful in certain circumstances, as alcohol reduces social anxiety). On the disease-centered account, antidepressants work by correcting a serotonin deficit. On the drug-centered account, they produce a blunted emotional range that some people find preferable to the emotional states associated with depression — without necessarily addressing its causes. Both accounts are compatible with the observation that many people feel better on medication. They imply very different things about what is happening, what the long-term effects might be, and whether "working" in the short term is the right metric. The difference matters because it changes what informed consent looks like: whether you are being told "this will correct what's wrong with your brain" or "this will change how you feel in ways that may help you function, with uncertain long-term effects."

Who defines disorder, and in whose interest? The Diagnostic and Statistical Manual — the document that defines mental illness for clinical, legal, and insurance purposes — is produced by committees within the American Psychiatric Association. Research by Lisa Cosgrove and Sheldon Krimsky has documented extensive financial ties between DSM panel members and pharmaceutical companies: in the DSM-IV, over half of the panel members reporting financial relationships with the industry; in the DSM-5, similar patterns persisted. Homosexuality was a psychiatric diagnosis until 1973, removed not by new biological evidence but by political organizing. Grief was protected from a depression diagnosis by the bereavement exclusion until the DSM-5 removed it. These facts do not prove that all psychiatric diagnoses are socially constructed fictions. They do establish that the DSM is a human artifact produced by people with interests, not a view from nowhere — and that the question of who controls the definition of pathology has real consequences for whose suffering gets named, treated, and taken seriously.

What sensemaking surfaces

Nadia's gratitude for her diagnosis is real, and it is not contaminated by the critique. The stabilization she experienced is real. The relief from years of self-blame is real. The critique of the medical model does not require concluding that Nadia was wrong to accept her diagnosis or wrong to take her medication. It requires only asking what the diagnosis did not ask — and being honest that what it did not ask may also have mattered. The most defensible position is not that the medical model is wrong but that it is incomplete, and that its incompleteness has been systematically underacknowledged in proportion to the institutional and economic interests invested in its completeness.

James's frustration with the cognitive restructuring framing is also real, and it is not refuted by pointing to people for whom that approach worked. What his experience surfaces is that the system has a preferred account of what is happening to a suffering person, and that preferred account has downstream effects on what treatment looks like and what questions the person is invited to ask. A system that treated his circumstances as legitimate objects of clinical attention — that asked whether there was something about the life he had been living that was worth changing, not just returning to — would have been doing something different from what he received. Whether that something would have helped him more, less, or differently is unknowable. What is clear is that the frame chosen was not neutral.

What the debate usually misses is that both traditions are trying to help real people who are suffering in real ways, and that the conflict between them has been sharpened by the same economic and institutional forces that complicate the science. Pharmaceutical companies have profited enormously from the disease model and have funded its propagation in ways that make it difficult to know which parts of the consensus reflect evidence and which reflect marketing. The critical tradition, meanwhile, sometimes responds to this with a totalism that makes it hard to see what the medical model genuinely provides at its strongest. What is most needed — and most absent from the current argument — is a framework capacious enough to say: this person's suffering is real; the circumstances that produced it are also real; the biological substrates that mediate it are real; and no single account of which of these is primary is adequate to all cases, or perhaps to any single case completely. That framework would require both traditions to give up the parts of their position that depend on the other being entirely wrong — which is, predictably, the part neither finds easy to surrender.